DESIGN THERAPEUTICS INC. - COMMON STOCK
5.6800
25-نوفمبر-24 10:17:44
15 متأخرة بدقائق
الأسهم
+0.0600
+1.07%
نطاق اليوم
5.6400 - 5.8900
ISIN
N/A
المصدر
NASDAQ
-
Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
08 أغسطس 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference
03 أغسطس 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the 2022 Jefferies Healthcare Conference
01 يونيو 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
09 مايو 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
30 مارس 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
10 مارس 2022 16:02:00 بحسب Nasdaq GlobeNewswire
-
09 مارس 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
28 فبراير 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
10 فبراير 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer
01 فبراير 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
09 نوفمبر 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
08 سبتمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
09 أغسطس 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
07 يونيو 2021 16:10:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics Expands Board of Directors with Key Appointments
07 يونيو 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
10 مايو 2021 16:05:00 بحسب Nasdaq GlobeNewswire